MedTrace Logo

ReNu™ Injection to Treat Hip Osteoarthritis Study

NCT03063099 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-01-14

No results posted yet for this study

Summary

A pilot study to evaluate changes in hip function and pain in patients with osteoarthritis receiving the ReNu™ Hip Injection.

Conditions

  • Osteoarthritis, Hip

Interventions

OTHER

ReNu™ Injection

Injection into the hip for the treatment of Osteoarthritis.

Sponsors & Collaborators

  • Organogenesis

    collaborator INDUSTRY

  • NuTech Medical, Inc

    lead INDUSTRY

Principal Investigators

  • Katie Mowry, PhD · Organogenesis

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-08
Primary Completion
2019-06-28
Completion
2019-06-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03063099 on ClinicalTrials.gov